Type I diabetes mellitus is a disease that results from autoimmune destruction of the insulin-producing beta-cells. Certain beta-cell proteins act as autoantigens after being processed by antigen-presenting cell (APC), such as macrophages and dendritic cells, and presented in a complex with MHC-II molecules on the surface of the APC. Then immunogenic signals from APC activate CD4+ T cells, predominantly of the Th1 subset. Antigen-activated Th1 cells produce IL-2 and IFNgamma. They activate macrophages and cytotoxic CD8+ T cells, and these effector cells may kill islet beta-cells by one or both of two types of mechanisms: (1) direct interactions of antigen-specific cytotoxic T cells with a beta-cell autoantigen-MHC-I complex on the beta-cell, and (2) non-specific inflammatory mediators, such as free radicals/oxidants and cytokines (IL-1, TNFalpha, TNFbeta, IFNgamma).
Type I diabetes is a polygenic disease. One of the principle determining genetic factors in diabetes incidence is the inheritance of mutant MHC-II alleles. Another plausible candidate gene is the insulin gene.

Human Diseases; Endocrine and metabolic diseases

PMID:9719467

Rabinovitch A, Suarez-Pinzon WL.

Cytokines and their roles in pancreatic islet beta-cell destruction and insulin-dependent diabetes mellitus.

Biochem Pharmacol 55:1139-49 (1998)
DOI:10.1016/S0006-2952(97)00492-9

PMID:11507694

Cox NJ, Wapelhorst B, Morrison VA, Johnson L, Pinchuk L, Spielman RS, Todd JA, Concannon P

Seven regions of the genome show evidence of linkage to type 1 diabetes in a consensus analysis of 767 multiplex families.

Am J Hum Genet 69:820-30 (2001)
DOI:10.1086/323501

PMID:8072542

Davies JL, Kawaguchi Y, Bennett ST, Copeman JB, Cordell HJ, Pritchard LE, Reed PW, Gough SC, Jenkins SC, Palmer SM, et al.

A genome-wide search for human type 1 diabetes susceptibility genes.

Nature 371:130-6 (1994)
DOI:10.1038/371130a0

PMID:8786033

Fujisawa T, Ikegami H, Kawaguchi Y, Yamato E, Takekawa K, Nakagawa Y, Hamada Y, Ueda H, Shima K, Ogihara T.

Class I HLA is associated with age-at-onset of IDDM, while class II HLA confers susceptibility to IDDM.

Diabetologia 38:1493-5 (1995)
DOI:10.1007/BF00400620

PMID:12796471

Jaeckel E, Klein L, Martin-Orozco N, von Boehmer H.

Normal incidence of diabetes in NOD mice tolerant to glutamic acid decarboxylase.

J Exp Med 197:1635-44 (2003)
DOI:10.1084/jem.20030215

PMID:15889095

Nakayama M, Abiru N, Moriyama H, Babaya N, Liu E, Miao D, Yu L, Wegmann DR, Hutton JC, Elliott JF, Eisenbarth GS.

Prime role for an insulin epitope in the development of type 1 diabetes in NOD mice.

Nature 435:220-3 (2005)
DOI:10.1038/nature03523

PMID:15889096

Kent SC, Chen Y, Bregoli L, Clemmings SM, Kenyon NS, Ricordi C, Hering BJ, Hafler DA.

Expanded T cells from pancreatic lymph nodes of type 1 diabetic subjects recognize an insulin epitope.

Nature 435:224-8 (2005)
DOI:10.1038/nature03625

PMID:14617043

Lieberman SM, DiLorenzo TP.

A comprehensive guide to antibody and T-cell responses in type 1 diabetes.

Tissue Antigens 62:359-77 (2003)
DOI:10.1034/j.1399-0039.2003.00152.x

PMID:12752668

Lord SJ, Rajotte RV, Korbutt GS, Bleackley RC.

Granzyme B: a natural born killer.

Immunol Rev 193:31-8 (2003)
DOI:10.1034/j.1600-065X.2003.00044.x